Celularity Inc — Director's Dealing 2022

Jul 16, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2022-07-13

Reporting Person: Fletcher Kyle (General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	33135	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$2.87	2028-02-20	Class A Common Stock (22708)		Direct
Stock Option (Right to Buy)	$3.88	2028-12-03	Class A Common Stock (11354)		Direct
Stock Option (Right to Buy)	$3.70	2030-02-06	Class A Common Stock (34936)		Direct
Stock Option (Right to Buy)	$8.71	2032-03-31	Class A Common Stock (26318)		Direct

Footnotes

F1: Represents restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan). Each RSU represents the right to receive one share of the Issuer's Class A common stock. The RSUs underlying this award vest and become exercisable over a four-year period, with 25% vesting on the one-year anniversary of the grant date, with the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

F2: These options were granted under the Issuer's Amended and Restated 2017 Equity Incentive Plan (the "2017 Plan") assumed in the business combination and 100% of the shares subject to the stock option are fully vested and exercisable as of the date hereof.

F3: This option was granted under the 2017 Plan and vests and becomes exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

F4: This option was granted under the 2021 Plan and vests and becomes exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.